ArticleACS omega2025
DRP-PSM: Multi-Level Feature Integration Reveals Hierarchical Contributions to Pathogenic Synonymous Mutation Prediction.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synonymous mutations, a unique class of genetic variants, do not change the amino acid sequence of the encoded protein. Despite this, they can impact protein stability and function through diverse molecular mechanisms. Such subtle alterations can contribute to disease initiation and progression, making the prediction of pathogenic synonymous mutations crucial for understanding disease mechanisms as well as improving clinical diagnosis and treatment. In this study, we introduce DRP-PSM, a novel method for predicting pathogenic synonymous mutations that integrates DNA, RNA, and protein-level biological features. Building upon our earlier method, DRP-PSM greatly expands the feature set by incorporating protein-level information alongside enriched DNA and RNA signatures. Our goal is to elucidate how features from distinct biological levels contribute to the pathogenicity of synonymous mutations and to construct a comprehensive, multilevel prediction framework. DRP-PSM systematically integrates DNA-, RNA-, and protein-level sequence and structural features. Experimental results indicate that DNA-level features contribute the most to prediction accuracy, followed by RNA-level features, whereas protein-level features add only marginal utility. Notably, incorporating additional sequence- and structure-based descriptors yielded little performance gain, while biological features such as DNA conservation and splicing effect consistently dominated. These findings highlight that synonymous mutations primarily exert pathogenic effects through perturbations in splicing or transcriptional efficiency, rather than through translational or post-translational processes. This insight enhances our mechanistic understanding of their biological impact and underscores regulatory mechanisms as key targets for future therapeutic intervention.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.